GeneDx Holdings Corp

WGS USD0.0001 A
Create an alert
Sell$98.56
Buy$99.74
$1.43 (1.41%)
Last updated today at
Back to dashboard

Company Information

About this company

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through the GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Genomic sequencing tests include whole genome sequencing, whole exome sequencing, prenatal genetic testing, targeted testing, pediatric neurology, general pediatrics, geneticists and genetic counsellors, and others. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

Key people

Jason Michael Ryan
Independent Chairman of the Board
Mark A. Gardner
President
Katherine A. Stueland
Chief Executive Officer and Director
Kevin Feeley
Chief Financial Officer
Bryan Dechairo
Chief Operating Officer
Eli D. Casdin
Independent Director
Thomas Fuchs
Independent Director
Emily M. Leproust
Independent Director
Keith A. Meister
Independent Director
Click to see more

Key facts

  • Shares in issue
    29.82m
  • EPIC
    WGS
  • ISIN
    US81663L2007
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $3.02bn
  • Employees
    1,300
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.